The Cigna Group financials
$275.26+1.26%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $273.85B | $246.15B | $194.10B | $179.36B | $172.52B | $159.16B | $152.18B | $47.17B |
| Gross profit | $24.51B | $24.99B | $24.01B | $22.34B | $21.40B | $22.96B | $23.69B | $14.85B |
| Gross margin | 9.0% | 10.2% | 12.4% | 12.5% | 12.4% | 14.4% | 15.6% | 31.5% |
| Operating income | $8.15B | $8.44B | $7.37B | $7.29B | $6.39B | $6.91B | $6.69B | $2.68B |
| Net income | $5.96B | $3.43B | $5.16B | $6.70B | $5.37B | $8.46B | $5.10B | $2.64B |
| Net margin | 2.2% | 1.4% | 2.7% | 3.7% | 3.1% | 5.3% | 3.4% | 5.6% |
| Diluted EPS | $22.18 | $12.12 | $17.39 | $21.41 | $15.75 | $22.96 | $13.44 | $10.54 |
| EBITDA | $10.93B | $11.22B | $10.40B | $10.23B | $9.31B | $9.71B | $10.34B | $3.38B |
| Operating cash flow | $9.60B | $10.36B | $11.81B | $8.66B | $7.19B | $10.35B | $9.48B | $3.77B |
| Free cash flow | $8.39B | $8.96B | $10.24B | $7.36B | $6.04B | $9.26B | $8.44B | $3.24B |
| Diluted shares | 268.6M | 283.2M | 296.9M | 313.1M | 341.0M | 368.4M | 379.8M | 250.2M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $7.68B | $7.55B | $7.82B | $5.92B | $5.08B | $10.18B |
| Short-term investments | $1.06B | $665.0M | $925.0M | $905.0M | $920.0M | $1.33B |
| Total debt | $31.46B | $31.97B | $30.93B | $31.09B | $33.67B | $32.92B |
| Total assets | $157.92B | $155.88B | $152.76B | $143.88B | $154.89B | $155.45B |
| Total liabilities | $116.05B | $114.64B | $106.41B | $99.13B | $107.70B | $105.06B |
| Shareholders' equity | $41.87B | $41.24B | $46.24B | $44.69B | $47.13B | $50.33B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology